Market Outlook
The global Medical Radioisotopes market size was valued at USD 668.3 million in 2022 and is forecast to a readjusted size of USD 886.3 million by 2029 with a CAGR of 4.1% during review period.
Nuclear medicine uses radiation to provide diagnostic information about the functioning of a person's specific organs, or to treat them. Diagnostic procedures using radioisotopes are now routine. Radiotherapy can be used to treat some medical conditions, especially cancer, using radiation to weaken or destroy particular targeted cells. The attributes of naturally decaying atoms, known as radioisotopes, give rise to several applications across many aspects of modern-day life. There is widespread awareness of the use of radiation and radioisotopes in medicine, particularly for diagnosis (identification) and therapy (treatment) of various medical conditions.
Global key medical radioisotopes manufacturers include NRG, IRE etc. The top 2 companies hold a share about 40%. Americas is the largest market, with a share about 45%, followed by Europe and APAC with the share about 25% and 23%.
This report is a detailed and comprehensive analysis for global Medical Radioisotopes market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2023, are provided.
Key Features:
Global Medical Radioisotopes market size and forecasts, in consumption value ($ Million), 2018-2029
Global Medical Radioisotopes market size and forecasts by region and country, in consumption value ($ Million), 2018-2029
Global Medical Radioisotopes market size and forecasts, by Type and by Application, in consumption value ($ Million), 2018-2029
Global Medical Radioisotopes market shares of main players, in revenue ($ Million), 2018-2023
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Medical Radioisotopes
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Medical Radioisotopes market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Key Market Players
NRG
IRE
ANSTO
NTP Radioisotopes
China National Nuclear Corporation
Rosatom
Nordion
Eckert & Ziegler Strahlen
Polatom
Segmentation By Type
Tc-99m
Cobalt-60
Iodine Radioisotopes
Segmentation By Application
Nuclear Therapy
Equipment Radioactive Source
Diagnosis
Others
Segmentation By Region
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia and Rest of Asia-Pacific)
South America (Brazil, Argentina and Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
Market SWOT Analysis
What are the strengths of the Medical Radioisotopes Market in 2025?
The strengths lie in the increasing demand for medical imaging and cancer treatments, where radioisotopes play a crucial role. The advancement in technology, like hybrid imaging systems, and the growing adoption of nuclear medicine in diagnosis and therapy are also significant contributors. Moreover, the expanding healthcare infrastructure, especially in emerging markets, supports the market's growth.
What are the weaknesses of the Medical Radioisotopes Market in 2025?
One weakness is the reliance on a few major suppliers and the complexities around supply chain disruptions, particularly in the production of isotopes. The short half-lives of certain radioisotopes also present logistical challenges in transportation and storage. Additionally, there’s the issue of high production costs, which could limit accessibility in low-resource settings.
What opportunities are available for the Medical Radioisotopes Market in 2025?
There are significant opportunities in the development of new radioisotopes for targeted cancer therapies, as well as expanding the use of theranostics (a combination of therapy and diagnostics). Additionally, collaborations between biotech companies and healthcare providers for innovative solutions can enhance market growth. The growing demand for personalized medicine offers an expanding niche for radioisotope applications.
What threats could impact the Medical Radioisotopes Market in 2025?
Regulatory hurdles and stringent safety standards can limit market expansion. Moreover, the global shift towards more cost-effective medical treatments may limit the use of radioisotopes due to their expensive nature. There’s also the threat of nuclear accidents or environmental concerns related to radioactive materials, which could negatively impact public perception and market growth.
Market PESTEL Analysis
What are the political factors influencing the Medical Radioisotopes Market in 2025?
Political factors include government regulations related to the production, use, and disposal of radioactive materials. Additionally, the stability of international relations plays a role in global trade of medical radioisotopes, as supply chains may be affected by political tensions. Policies that support nuclear energy and healthcare infrastructure also positively influence the market.
How do economic factors impact the Medical Radioisotopes Market in 2025?
Economic factors such as healthcare funding and economic stability in various regions are crucial. The cost of radioisotope production can be high, affecting pricing and accessibility. Economic downturns may lead to budget cuts in healthcare, which could limit the adoption of expensive medical technologies like nuclear medicine. On the other hand, economic growth in emerging markets could increase demand.
What are the social factors affecting the Medical Radioisotopes Market in 2025?
Social factors include the growing awareness and acceptance of nuclear medicine for diagnostics and therapy, especially for cancer treatment. The aging population, which is more likely to need advanced diagnostic imaging, contributes to increased demand. However, public concerns over radiation safety may impact the market's adoption and development.
How do technological factors shape the Medical Radioisotopes Market in 2025?
Technological advancements in medical imaging, such as hybrid systems that combine PET and CT scans, drive the demand for medical radioisotopes. Improvements in isotope production techniques and the development of new, more effective radioisotopes for therapy and diagnostics also play a key role in shaping the market. Additionally, innovations in radiopharmaceuticals and precision medicine offer substantial growth opportunities.
What are the environmental factors influencing the Medical Radioisotopes Market in 2025?
Environmental factors include the safe handling, transportation, and disposal of radioactive materials. Environmental regulations governing the production of medical radioisotopes and their impact on ecosystems are crucial. There is also increasing pressure on the industry to minimize the carbon footprint of nuclear medicine and ensure sustainable practices throughout the supply chain.
What legal factors are relevant to the Medical Radioisotopes Market in 2025?
Legal factors involve strict regulations concerning the use of radioactive materials, including safety standards for production, storage, and disposal. Compliance with international treaties and agreements on nuclear safety is essential. Legal frameworks around intellectual property for innovations in radioisotope production and therapeutic use also influence market dynamics.
Market SIPOC Analysis
Who are the suppliers in the Medical Radioisotopes Market in 2025?
Suppliers include companies that produce radioactive materials, such as nuclear reactors, cyclotrons, and radiopharmaceutical manufacturers. These suppliers are responsible for providing the raw materials necessary to create medical radioisotopes. Additionally, equipment suppliers for imaging systems like PET and SPECT scanners are key players in the supply chain.
What inputs are required for the Medical Radioisotopes Market in 2025?
Inputs include raw materials such as uranium and molybdenum for isotope production, advanced nuclear technology for synthesis, and highly specialized equipment for imaging and diagnostics. Skilled workforce, regulatory compliance, and access to secure supply chains are also critical inputs for ensuring safe and efficient production.
What are the processes involved in the Medical Radioisotopes Market in 2025?
The key processes include the production of radioisotopes through nuclear reactors or cyclotrons, the packaging and transportation of isotopes to hospitals and clinics, and the preparation of radiopharmaceuticals. Additional processes involve quality control to ensure the isotopes meet regulatory safety standards, as well as the integration of these isotopes into diagnostic and therapeutic procedures.
Who are the customers in the Medical Radioisotopes Market in 2025?
Customers include hospitals, diagnostic imaging centers, oncology clinics, and research institutions. These customers utilize medical radioisotopes for diagnostic imaging (e.g., PET and SPECT scans) and cancer treatments, such as radiotherapy. Healthcare providers across both developed and emerging markets are significant end-users of these products.
What are the outputs in the Medical Radioisotopes Market in 2025?
Outputs include the medical radioisotopes themselves, which are used in imaging and therapeutic applications, and the radiopharmaceuticals derived from these isotopes. The outputs also consist of diagnostic reports, medical treatments, and research advancements, all of which contribute to better patient care, particularly in oncology and cardiology.
Market Porter's Five Forces
What is the threat of new entrants in the Medical Radioisotopes Market in 2025?
The threat of new entrants is relatively low due to high barriers to entry, including the significant capital investment required for nuclear reactors or cyclotrons, regulatory approvals, and the specialized expertise needed in handling radioactive materials. The strict regulatory environment and the complex distribution logistics also deter new competitors from entering the market.
What is the bargaining power of suppliers in the Medical Radioisotopes Market in 2025?
Suppliers have moderate to high bargaining power in this market due to the specialized nature of medical radioisotope production. There are limited suppliers of the raw materials and equipment necessary for isotope production, and any disruption in their supply can significantly impact the market. However, the increasing technological advancements and potential for new suppliers may reduce their power over time.
What is the bargaining power of buyers in the Medical Radioisotopes Market in 2025?
Buyers, such as hospitals and healthcare providers, hold moderate bargaining power. While medical radioisotopes are essential for certain diagnostic and therapeutic procedures, buyers may negotiate prices due to the competitive nature of the healthcare industry. However, the necessity of these isotopes and the lack of substitutes limit their bargaining leverage.
What is the threat of substitute products in the Medical Radioisotopes Market in 2025?
The threat of substitutes is low, as there are few alternatives to medical radioisotopes in diagnostic imaging and cancer therapy. While other imaging technologies like MRI or CT scans exist, they do not provide the same molecular-level insights and targeted treatment options that radioisotopes offer, particularly in oncology. This makes radioisotopes irreplaceable for certain medical applications.
What is the intensity of competitive rivalry in the Medical Radioisotopes Market in 2025?
The competitive rivalry is moderate to high, with several established players in the market, including large pharmaceutical companies and specialized producers of medical radioisotopes. However, due to the specialized nature of the market, competition is more concentrated in certain regions, and companies often collaborate with healthcare providers and research institutions to stay competitive.
Market Upstream Analysis
What are the key raw materials for the Medical Radioisotopes Market in 2025?
The key raw materials include isotopes such as molybdenum-99, uranium, and other elements that are used in nuclear reactors or cyclotrons to produce medical radioisotopes. These materials are essential for generating the specific isotopes used in diagnostic and therapeutic applications.
What suppliers are critical to the Medical Radioisotopes Market in 2025?
Critical suppliers include companies that operate nuclear reactors or cyclotrons for isotope production, as well as those who supply radiopharmaceutical raw materials. Additionally, suppliers of specialized equipment for medical imaging, like PET and SPECT scanners, are vital to ensuring the smooth delivery of radioisotopes to healthcare providers.
How does the production process impact the upstream segment of the Medical Radioisotopes Market in 2025?
The production process for medical radioisotopes is highly specialized, requiring complex nuclear reactions and advanced technology. This process is impacted by strict regulatory controls around safety and environmental concerns. Additionally, limited global supply capabilities and high costs associated with reactor operations and raw material procurement create challenges in the upstream segment.
What are the main challenges faced by the upstream segment of the Medical Radioisotopes Market in 2025?
Key challenges include the scarcity of certain raw materials, such as molybdenum-99, and the high costs associated with their production. Regulatory constraints and the need for rigorous safety protocols in isotope handling also add complexity to the upstream segment. Furthermore, supply chain disruptions or accidents at nuclear facilities can severely impact the availability of isotopes.
What opportunities exist in the upstream segment of the Medical Radioisotopes Market in 2025?
Opportunities include the potential for advancements in isotope production technologies, such as more efficient cyclotron or reactor-based systems, which could lower production costs. There is also room for innovation in raw material sourcing, including the development of alternative, more sustainable methods for producing key isotopes. Expanding collaborations with research institutions and healthcare providers presents further opportunities for growth in the upstream segment.
Market Midstream Analysis
What are the key processes in the midstream segment of the Medical Radioisotopes Market in 2025?
The key processes include the transportation, distribution, and safe handling of medical radioisotopes from the production facilities to healthcare providers. This segment also involves the packaging and storage of isotopes, ensuring compliance with safety regulations and maintaining the required temperature and radiation levels to preserve the isotopes' efficacy.
What are the challenges faced by the midstream segment in the Medical Radioisotopes Market in 2025?
Challenges include logistical difficulties related to the short half-life of many radioisotopes, which requires rapid transportation to ensure they reach healthcare providers in time for use. Additionally, ensuring compliance with international and regional safety standards during transport, as well as managing the risks associated with handling radioactive materials, poses significant challenges.
What are the main players involved in the midstream segment of the Medical Radioisotopes Market in 2025?
Key players in the midstream segment include logistics and supply chain companies specializing in the transportation of radioactive materials, as well as distributors that facilitate the supply of isotopes to hospitals, diagnostic centers, and oncology clinics. These companies must work closely with regulatory bodies to ensure safety and compliance during the transport and delivery process.
What role does technology play in the midstream segment of the Medical Radioisotopes Market in 2025?
Technology plays a critical role in ensuring the safe and efficient handling, tracking, and transportation of medical radioisotopes. Advancements in temperature-controlled packaging, GPS tracking for delivery, and monitoring systems for radiation levels help improve the reliability and safety of the supply chain. Furthermore, digital systems for regulatory compliance and documentation streamline the process.
What opportunities exist in the midstream segment of the Medical Radioisotopes Market in 2025?
Opportunities include the development of more advanced, efficient, and cost-effective transportation solutions, such as specialized containers for longer shelf-life isotopes or innovations in packaging to ensure higher safety standards. Additionally, as demand for nuclear medicine increases, expanding distribution networks, particularly in emerging markets, presents a significant growth opportunity in this segment.
Market Downstream Analysis
What are the key activities in the downstream segment of the Medical Radioisotopes Market in 2025?
The key activities in the downstream segment include the use of medical radioisotopes in diagnostic imaging (such as PET and SPECT scans) and therapeutic applications, particularly in oncology. This segment also involves the administration of radiopharmaceuticals to patients, post-treatment care, and the monitoring of treatment efficacy. Additionally, healthcare providers focus on patient education and managing the logistics of isotope usage within medical facilities.
What challenges are faced by the downstream segment of the Medical Radioisotopes Market in 2025?
Challenges include the high cost of radiopharmaceuticals, which can limit accessibility, particularly in low-resource settings. The short half-life of many isotopes demands precise coordination and timely delivery, putting pressure on healthcare systems. Additionally, there are concerns about radiation safety and the potential health risks associated with handling and administering radioactive substances, requiring strict compliance with safety protocols.
Who are the key players in the downstream segment of the Medical Radioisotopes Market in 2025?
Key players in the downstream segment include hospitals, diagnostic imaging centers, oncology clinics, and specialized radiology departments. Additionally, healthcare professionals, including radiologists, oncologists, and nuclear medicine specialists, are critical in the delivery of services involving medical radioisotopes. Pharmaceutical companies that provide radiopharmaceuticals also play a significant role in the downstream activities.
How does technology impact the downstream segment of the Medical Radioisotopes Market in 2025?
Technology plays a pivotal role in enhancing the precision and efficiency of diagnostic imaging and therapy. Advancements in imaging equipment, such as more advanced PET and SPECT scanners, enable better detection and monitoring of diseases like cancer. Additionally, innovations in radiopharmaceuticals, including more targeted therapies and personalized medicine, enhance treatment outcomes. Improved patient management systems also support the efficient use of radioisotopes.
What opportunities exist in the downstream segment of the Medical Radioisotopes Market in 2025?
Opportunities in the downstream segment include the growing demand for precision medicine and theranostics, where radioisotopes are used not just for diagnosis but also for treatment. The rise in cancer cases, along with advances in nuclear medicine, presents opportunities for the increased use of radioisotopes in therapy. Expanding healthcare access in emerging markets and improving patient outcomes through personalized treatments offer additional growth potential.
Chapter 1, to describe Medical Radioisotopes product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Medical Radioisotopes, with revenue, gross margin and global market share of Medical Radioisotopes from 2018 to 2023.
Chapter 3, the Medical Radioisotopes competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and application, with consumption value and growth rate by Type, application, from 2018 to 2029.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2018 to 2023.and Medical Radioisotopes market forecast, by regions, type and application, with consumption value, from 2024 to 2029.
Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis, and Influence of COVID-19 and Russia-Ukraine War
Chapter 12, the key raw materials and key suppliers, and industry chain of Medical Radioisotopes.
Chapter 13, to describe Medical Radioisotopes research findings and conclusion.
1 Market Overview
1.1 Product Overview and Scope of Medical Radioisotopes
1.2 Market Estimation Caveats and Base Year
1.3 Classification of Medical Radioisotopes by Type
1.3.1 Overview: Global Medical Radioisotopes Market Size by Type: 2018 Versus 2022 Versus 2029
1.3.2 Global Medical Radioisotopes Consumption Value Market Share by Type in 2022
1.3.3 Tc-99m
1.3.4 Cobalt-60
1.3.5 Iodine Radioisotopes
1.4 Global Medical Radioisotopes Market by Application
1.4.1 Overview: Global Medical Radioisotopes Market Size by Application: 2018 Versus 2022 Versus 2029
1.4.2 Nuclear Therapy
1.4.3 Equipment Radioactive Source
1.4.4 Diagnosis
1.4.5 Others
1.5 Global Medical Radioisotopes Market Size & Forecast
1.6 Global Medical Radioisotopes Market Size and Forecast by Region
1.6.1 Global Medical Radioisotopes Market Size by Region: 2018 VS 2022 VS 2029
1.6.2 Global Medical Radioisotopes Market Size by Region, (2018-2029)
1.6.3 North America Medical Radioisotopes Market Size and Prospect (2018-2029)
1.6.4 Europe Medical Radioisotopes Market Size and Prospect (2018-2029)
1.6.5 Asia-Pacific Medical Radioisotopes Market Size and Prospect (2018-2029)
1.6.6 South America Medical Radioisotopes Market Size and Prospect (2018-2029)
1.6.7 Middle East and Africa Medical Radioisotopes Market Size and Prospect (2018-2029)
2 Company Profiles
2.1 NRG
2.1.1 NRG Details
2.1.2 NRG Major Business
2.1.3 NRG Medical Radioisotopes Product and Solutions
2.1.4 NRG Medical Radioisotopes Revenue, Gross Margin and Market Share (2018-2023)
2.1.5 NRG Recent Developments and Future Plans
2.2 IRE
2.2.1 IRE Details
2.2.2 IRE Major Business
2.2.3 IRE Medical Radioisotopes Product and Solutions
2.2.4 IRE Medical Radioisotopes Revenue, Gross Margin and Market Share (2018-2023)
2.2.5 IRE Recent Developments and Future Plans
2.3 ANSTO
2.3.1 ANSTO Details
2.3.2 ANSTO Major Business
2.3.3 ANSTO Medical Radioisotopes Product and Solutions
2.3.4 ANSTO Medical Radioisotopes Revenue, Gross Margin and Market Share (2018-2023)
2.3.5 ANSTO Recent Developments and Future Plans
2.4 NTP Radioisotopes
2.4.1 NTP Radioisotopes Details
2.4.2 NTP Radioisotopes Major Business
2.4.3 NTP Radioisotopes Medical Radioisotopes Product and Solutions
2.4.4 NTP Radioisotopes Medical Radioisotopes Revenue, Gross Margin and Market Share (2018-2023)
2.4.5 NTP Radioisotopes Recent Developments and Future Plans
2.5 China National Nuclear Corporation
2.5.1 China National Nuclear Corporation Details
2.5.2 China National Nuclear Corporation Major Business
2.5.3 China National Nuclear Corporation Medical Radioisotopes Product and Solutions
2.5.4 China National Nuclear Corporation Medical Radioisotopes Revenue, Gross Margin and Market Share (2018-2023)
2.5.5 China National Nuclear Corporation Recent Developments and Future Plans
2.6 Rosatom
2.6.1 Rosatom Details
2.6.2 Rosatom Major Business
2.6.3 Rosatom Medical Radioisotopes Product and Solutions
2.6.4 Rosatom Medical Radioisotopes Revenue, Gross Margin and Market Share (2018-2023)
2.6.5 Rosatom Recent Developments and Future Plans
2.7 Nordion
2.7.1 Nordion Details
2.7.2 Nordion Major Business
2.7.3 Nordion Medical Radioisotopes Product and Solutions
2.7.4 Nordion Medical Radioisotopes Revenue, Gross Margin and Market Share (2018-2023)
2.7.5 Nordion Recent Developments and Future Plans
2.8 Eckert & Ziegler Strahlen
2.8.1 Eckert & Ziegler Strahlen Details
2.8.2 Eckert & Ziegler Strahlen Major Business
2.8.3 Eckert & Ziegler Strahlen Medical Radioisotopes Product and Solutions
2.8.4 Eckert & Ziegler Strahlen Medical Radioisotopes Revenue, Gross Margin and Market Share (2018-2023)
2.8.5 Eckert & Ziegler Strahlen Recent Developments and Future Plans
2.9 Polatom
2.9.1 Polatom Details
2.9.2 Polatom Major Business
2.9.3 Polatom Medical Radioisotopes Product and Solutions
2.9.4 Polatom Medical Radioisotopes Revenue, Gross Margin and Market Share (2018-2023)
2.9.5 Polatom Recent Developments and Future Plans
3 Market Competition, by Players
3.1 Global Medical Radioisotopes Revenue and Share by Players (2018-2023)
3.2 Market Share Analysis (2022)
3.2.1 Market Share of Medical Radioisotopes by Company Revenue
3.2.2 Top 3 Medical Radioisotopes Players Market Share in 2022
3.2.3 Top 6 Medical Radioisotopes Players Market Share in 2022
3.3 Medical Radioisotopes Market: Overall Company Footprint Analysis
3.3.1 Medical Radioisotopes Market: Region Footprint
3.3.2 Medical Radioisotopes Market: Company Product Type Footprint
3.3.3 Medical Radioisotopes Market: Company Product Application Footprint
3.4 New Market Entrants and Barriers to Market Entry
3.5 Mergers, Acquisition, Agreements, and Collaborations
4 Market Size Segment by Type
4.1 Global Medical Radioisotopes Consumption Value and Market Share by Type (2018-2023)
4.2 Global Medical Radioisotopes Market Forecast by Type (2024-2029)
5 Market Size Segment by Application
5.1 Global Medical Radioisotopes Consumption Value Market Share by Application (2018-2023)
5.2 Global Medical Radioisotopes Market Forecast by Application (2024-2029)
6 North America
6.1 North America Medical Radioisotopes Consumption Value by Type (2018-2029)
6.2 North America Medical Radioisotopes Consumption Value by Application (2018-2029)
6.3 North America Medical Radioisotopes Market Size by Country
6.3.1 North America Medical Radioisotopes Consumption Value by Country (2018-2029)
6.3.2 United States Medical Radioisotopes Market Size and Forecast (2018-2029)
6.3.3 Canada Medical Radioisotopes Market Size and Forecast (2018-2029)
6.3.4 Mexico Medical Radioisotopes Market Size and Forecast (2018-2029)
7 Europe
7.1 Europe Medical Radioisotopes Consumption Value by Type (2018-2029)
7.2 Europe Medical Radioisotopes Consumption Value by Application (2018-2029)
7.3 Europe Medical Radioisotopes Market Size by Country
7.3.1 Europe Medical Radioisotopes Consumption Value by Country (2018-2029)
7.3.2 Germany Medical Radioisotopes Market Size and Forecast (2018-2029)
7.3.3 France Medical Radioisotopes Market Size and Forecast (2018-2029)
7.3.4 United Kingdom Medical Radioisotopes Market Size and Forecast (2018-2029)
7.3.5 Russia Medical Radioisotopes Market Size and Forecast (2018-2029)
7.3.6 Italy Medical Radioisotopes Market Size and Forecast (2018-2029)
8 Asia-Pacific
8.1 Asia-Pacific Medical Radioisotopes Consumption Value by Type (2018-2029)
8.2 Asia-Pacific Medical Radioisotopes Consumption Value by Application (2018-2029)
8.3 Asia-Pacific Medical Radioisotopes Market Size by Region
8.3.1 Asia-Pacific Medical Radioisotopes Consumption Value by Region (2018-2029)
8.3.2 China Medical Radioisotopes Market Size and Forecast (2018-2029)
8.3.3 Japan Medical Radioisotopes Market Size and Forecast (2018-2029)
8.3.4 South Korea Medical Radioisotopes Market Size and Forecast (2018-2029)
8.3.5 India Medical Radioisotopes Market Size and Forecast (2018-2029)
8.3.6 Southeast Asia Medical Radioisotopes Market Size and Forecast (2018-2029)
8.3.7 Australia Medical Radioisotopes Market Size and Forecast (2018-2029)
9 South America
9.1 South America Medical Radioisotopes Consumption Value by Type (2018-2029)
9.2 South America Medical Radioisotopes Consumption Value by Application (2018-2029)
9.3 South America Medical Radioisotopes Market Size by Country
9.3.1 South America Medical Radioisotopes Consumption Value by Country (2018-2029)
9.3.2 Brazil Medical Radioisotopes Market Size and Forecast (2018-2029)
9.3.3 Argentina Medical Radioisotopes Market Size and Forecast (2018-2029)
10 Middle East & Africa
10.1 Middle East & Africa Medical Radioisotopes Consumption Value by Type (2018-2029)
10.2 Middle East & Africa Medical Radioisotopes Consumption Value by Application (2018-2029)
10.3 Middle East & Africa Medical Radioisotopes Market Size by Country
10.3.1 Middle East & Africa Medical Radioisotopes Consumption Value by Country (2018-2029)
10.3.2 Turkey Medical Radioisotopes Market Size and Forecast (2018-2029)
10.3.3 Saudi Arabia Medical Radioisotopes Market Size and Forecast (2018-2029)
10.3.4 UAE Medical Radioisotopes Market Size and Forecast (2018-2029)
11 Market Dynamics
11.1 Medical Radioisotopes Market Drivers
11.2 Medical Radioisotopes Market Restraints
11.3 Medical Radioisotopes Trends Analysis
11.4 Porters Five Forces Analysis
11.4.1 Threat of New Entrants
11.4.2 Bargaining Power of Suppliers
11.4.3 Bargaining Power of Buyers
11.4.4 Threat of Substitutes
11.4.5 Competitive Rivalry
11.5 Influence of COVID-19 and Russia-Ukraine War
11.5.1 Influence of COVID-19
11.5.2 Influence of Russia-Ukraine War
12 Industry Chain Analysis
12.1 Medical Radioisotopes Industry Chain
12.2 Medical Radioisotopes Upstream Analysis
12.3 Medical Radioisotopes Midstream Analysis
12.4 Medical Radioisotopes Downstream Analysis
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer
List of Tables
Table 1. Global Medical Radioisotopes Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Table 2. Global Medical Radioisotopes Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Table 3. Global Medical Radioisotopes Consumption Value by Region (2018-2023) & (USD Million)
Table 4. Global Medical Radioisotopes Consumption Value by Region (2024-2029) & (USD Million)
Table 5. NRG Company Information, Head Office, and Major Competitors
Table 6. NRG Major Business
Table 7. NRG Medical Radioisotopes Product and Solutions
Table 8. NRG Medical Radioisotopes Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 9. NRG Recent Developments and Future Plans
Table 10. IRE Company Information, Head Office, and Major Competitors
Table 11. IRE Major Business
Table 12. IRE Medical Radioisotopes Product and Solutions
Table 13. IRE Medical Radioisotopes Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 14. IRE Recent Developments and Future Plans
Table 15. ANSTO Company Information, Head Office, and Major Competitors
Table 16. ANSTO Major Business
Table 17. ANSTO Medical Radioisotopes Product and Solutions
Table 18. ANSTO Medical Radioisotopes Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 19. ANSTO Recent Developments and Future Plans
Table 20. NTP Radioisotopes Company Information, Head Office, and Major Competitors
Table 21. NTP Radioisotopes Major Business
Table 22. NTP Radioisotopes Medical Radioisotopes Product and Solutions
Table 23. NTP Radioisotopes Medical Radioisotopes Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 24. NTP Radioisotopes Recent Developments and Future Plans
Table 25. China National Nuclear Corporation Company Information, Head Office, and Major Competitors
Table 26. China National Nuclear Corporation Major Business
Table 27. China National Nuclear Corporation Medical Radioisotopes Product and Solutions
Table 28. China National Nuclear Corporation Medical Radioisotopes Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 29. China National Nuclear Corporation Recent Developments and Future Plans
Table 30. Rosatom Company Information, Head Office, and Major Competitors
Table 31. Rosatom Major Business
Table 32. Rosatom Medical Radioisotopes Product and Solutions
Table 33. Rosatom Medical Radioisotopes Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 34. Rosatom Recent Developments and Future Plans
Table 35. Nordion Company Information, Head Office, and Major Competitors
Table 36. Nordion Major Business
Table 37. Nordion Medical Radioisotopes Product and Solutions
Table 38. Nordion Medical Radioisotopes Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 39. Nordion Recent Developments and Future Plans
Table 40. Eckert & Ziegler Strahlen Company Information, Head Office, and Major Competitors
Table 41. Eckert & Ziegler Strahlen Major Business
Table 42. Eckert & Ziegler Strahlen Medical Radioisotopes Product and Solutions
Table 43. Eckert & Ziegler Strahlen Medical Radioisotopes Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 44. Eckert & Ziegler Strahlen Recent Developments and Future Plans
Table 45. Polatom Company Information, Head Office, and Major Competitors
Table 46. Polatom Major Business
Table 47. Polatom Medical Radioisotopes Product and Solutions
Table 48. Polatom Medical Radioisotopes Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 49. Polatom Recent Developments and Future Plans
Table 50. Global Medical Radioisotopes Revenue (USD Million) by Players (2018-2023)
Table 51. Global Medical Radioisotopes Revenue Share by Players (2018-2023)
Table 52. Breakdown of Medical Radioisotopes by Company Type (Tier 1, Tier 2, and Tier 3)
Table 53. Market Position of Players in Medical Radioisotopes, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2022
Table 54. Head Office of Key Medical Radioisotopes Players
Table 55. Medical Radioisotopes Market: Company Product Type Footprint
Table 56. Medical Radioisotopes Market: Company Product Application Footprint
Table 57. Medical Radioisotopes New Market Entrants and Barriers to Market Entry
Table 58. Medical Radioisotopes Mergers, Acquisition, Agreements, and Collaborations
Table 59. Global Medical Radioisotopes Consumption Value (USD Million) by Type (2018-2023)
Table 60. Global Medical Radioisotopes Consumption Value Share by Type (2018-2023)
Table 61. Global Medical Radioisotopes Consumption Value Forecast by Type (2024-2029)
Table 62. Global Medical Radioisotopes Consumption Value by Application (2018-2023)
Table 63. Global Medical Radioisotopes Consumption Value Forecast by Application (2024-2029)
Table 64. North America Medical Radioisotopes Consumption Value by Type (2018-2023) & (USD Million)
Table 65. North America Medical Radioisotopes Consumption Value by Type (2024-2029) & (USD Million)
Table 66. North America Medical Radioisotopes Consumption Value by Application (2018-2023) & (USD Million)
Table 67. North America Medical Radioisotopes Consumption Value by Application (2024-2029) & (USD Million)
Table 68. North America Medical Radioisotopes Consumption Value by Country (2018-2023) & (USD Million)
Table 69. North America Medical Radioisotopes Consumption Value by Country (2024-2029) & (USD Million)
Table 70. Europe Medical Radioisotopes Consumption Value by Type (2018-2023) & (USD Million)
Table 71. Europe Medical Radioisotopes Consumption Value by Type (2024-2029) & (USD Million)
Table 72. Europe Medical Radioisotopes Consumption Value by Application (2018-2023) & (USD Million)
Table 73. Europe Medical Radioisotopes Consumption Value by Application (2024-2029) & (USD Million)
Table 74. Europe Medical Radioisotopes Consumption Value by Country (2018-2023) & (USD Million)
Table 75. Europe Medical Radioisotopes Consumption Value by Country (2024-2029) & (USD Million)
Table 76. Asia-Pacific Medical Radioisotopes Consumption Value by Type (2018-2023) & (USD Million)
Table 77. Asia-Pacific Medical Radioisotopes Consumption Value by Type (2024-2029) & (USD Million)
Table 78. Asia-Pacific Medical Radioisotopes Consumption Value by Application (2018-2023) & (USD Million)
Table 79. Asia-Pacific Medical Radioisotopes Consumption Value by Application (2024-2029) & (USD Million)
Table 80. Asia-Pacific Medical Radioisotopes Consumption Value by Region (2018-2023) & (USD Million)
Table 81. Asia-Pacific Medical Radioisotopes Consumption Value by Region (2024-2029) & (USD Million)
Table 82. South America Medical Radioisotopes Consumption Value by Type (2018-2023) & (USD Million)
Table 83. South America Medical Radioisotopes Consumption Value by Type (2024-2029) & (USD Million)
Table 84. South America Medical Radioisotopes Consumption Value by Application (2018-2023) & (USD Million)
Table 85. South America Medical Radioisotopes Consumption Value by Application (2024-2029) & (USD Million)
Table 86. South America Medical Radioisotopes Consumption Value by Country (2018-2023) & (USD Million)
Table 87. South America Medical Radioisotopes Consumption Value by Country (2024-2029) & (USD Million)
Table 88. Middle East & Africa Medical Radioisotopes Consumption Value by Type (2018-2023) & (USD Million)
Table 89. Middle East & Africa Medical Radioisotopes Consumption Value by Type (2024-2029) & (USD Million)
Table 90. Middle East & Africa Medical Radioisotopes Consumption Value by Application (2018-2023) & (USD Million)
Table 91. Middle East & Africa Medical Radioisotopes Consumption Value by Application (2024-2029) & (USD Million)
Table 92. Middle East & Africa Medical Radioisotopes Consumption Value by Country (2018-2023) & (USD Million)
Table 93. Middle East & Africa Medical Radioisotopes Consumption Value by Country (2024-2029) & (USD Million)
Table 94. Medical Radioisotopes Raw Material
Table 95. Key Suppliers of Medical Radioisotopes Raw Materials
List of Figures
Figure 1. Medical Radioisotopes Picture
Figure 2. Global Medical Radioisotopes Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 3. Global Medical Radioisotopes Consumption Value Market Share by Type in 2022
Figure 4. Tc-99m
Figure 5. Cobalt-60
Figure 6. Iodine Radioisotopes
Figure 7. Global Medical Radioisotopes Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 8. Medical Radioisotopes Consumption Value Market Share by Application in 2022
Figure 9. Nuclear Therapy Picture
Figure 10. Equipment Radioactive Source Picture
Figure 11. Diagnosis Picture
Figure 12. Others Picture
Figure 13. Global Medical Radioisotopes Consumption Value, (USD Million): 2018 & 2022 & 2029
Figure 14. Global Medical Radioisotopes Consumption Value and Forecast (2018-2029) & (USD Million)
Figure 15. Global Market Medical Radioisotopes Consumption Value (USD Million) Comparison by Region (2018 & 2022 & 2029)
Figure 16. Global Medical Radioisotopes Consumption Value Market Share by Region (2018-2029)
Figure 17. Global Medical Radioisotopes Consumption Value Market Share by Region in 2022
Figure 18. North America Medical Radioisotopes Consumption Value (2018-2029) & (USD Million)
Figure 19. Europe Medical Radioisotopes Consumption Value (2018-2029) & (USD Million)
Figure 20. Asia-Pacific Medical Radioisotopes Consumption Value (2018-2029) & (USD Million)
Figure 21. South America Medical Radioisotopes Consumption Value (2018-2029) & (USD Million)
Figure 22. Middle East and Africa Medical Radioisotopes Consumption Value (2018-2029) & (USD Million)
Figure 23. Global Medical Radioisotopes Revenue Share by Players in 2022
Figure 24. Medical Radioisotopes Market Share by Company Type (Tier 1, Tier 2 and Tier 3) in 2022
Figure 25. Global Top 3 Players Medical Radioisotopes Market Share in 2022
Figure 26. Global Top 6 Players Medical Radioisotopes Market Share in 2022
Figure 27. Global Medical Radioisotopes Consumption Value Share by Type (2018-2023)
Figure 28. Global Medical Radioisotopes Market Share Forecast by Type (2024-2029)
Figure 29. Global Medical Radioisotopes Consumption Value Share by Application (2018-2023)
Figure 30. Global Medical Radioisotopes Market Share Forecast by Application (2024-2029)
Figure 31. North America Medical Radioisotopes Consumption Value Market Share by Type (2018-2029)
Figure 32. North America Medical Radioisotopes Consumption Value Market Share by Application (2018-2029)
Figure 33. North America Medical Radioisotopes Consumption Value Market Share by Country (2018-2029)
Figure 34. United States Medical Radioisotopes Consumption Value (2018-2029) & (USD Million)
Figure 35. Canada Medical Radioisotopes Consumption Value (2018-2029) & (USD Million)
Figure 36. Mexico Medical Radioisotopes Consumption Value (2018-2029) & (USD Million)
Figure 37. Europe Medical Radioisotopes Consumption Value Market Share by Type (2018-2029)
Figure 38. Europe Medical Radioisotopes Consumption Value Market Share by Application (2018-2029)
Figure 39. Europe Medical Radioisotopes Consumption Value Market Share by Country (2018-2029)
Figure 40. Germany Medical Radioisotopes Consumption Value (2018-2029) & (USD Million)
Figure 41. France Medical Radioisotopes Consumption Value (2018-2029) & (USD Million)
Figure 42. United Kingdom Medical Radioisotopes Consumption Value (2018-2029) & (USD Million)
Figure 43. Russia Medical Radioisotopes Consumption Value (2018-2029) & (USD Million)
Figure 44. Italy Medical Radioisotopes Consumption Value (2018-2029) & (USD Million)
Figure 45. Asia-Pacific Medical Radioisotopes Consumption Value Market Share by Type (2018-2029)
Figure 46. Asia-Pacific Medical Radioisotopes Consumption Value Market Share by Application (2018-2029)
Figure 47. Asia-Pacific Medical Radioisotopes Consumption Value Market Share by Region (2018-2029)
Figure 48. China Medical Radioisotopes Consumption Value (2018-2029) & (USD Million)
Figure 49. Japan Medical Radioisotopes Consumption Value (2018-2029) & (USD Million)
Figure 50. South Korea Medical Radioisotopes Consumption Value (2018-2029) & (USD Million)
Figure 51. India Medical Radioisotopes Consumption Value (2018-2029) & (USD Million)
Figure 52. Southeast Asia Medical Radioisotopes Consumption Value (2018-2029) & (USD Million)
Figure 53. Australia Medical Radioisotopes Consumption Value (2018-2029) & (USD Million)
Figure 54. South America Medical Radioisotopes Consumption Value Market Share by Type (2018-2029)
Figure 55. South America Medical Radioisotopes Consumption Value Market Share by Application (2018-2029)
Figure 56. South America Medical Radioisotopes Consumption Value Market Share by Country (2018-2029)
Figure 57. Brazil Medical Radioisotopes Consumption Value (2018-2029) & (USD Million)
Figure 58. Argentina Medical Radioisotopes Consumption Value (2018-2029) & (USD Million)
Figure 59. Middle East and Africa Medical Radioisotopes Consumption Value Market Share by Type (2018-2029)
Figure 60. Middle East and Africa Medical Radioisotopes Consumption Value Market Share by Application (2018-2029)
Figure 61. Middle East and Africa Medical Radioisotopes Consumption Value Market Share by Country (2018-2029)
Figure 62. Turkey Medical Radioisotopes Consumption Value (2018-2029) & (USD Million)
Figure 63. Saudi Arabia Medical Radioisotopes Consumption Value (2018-2029) & (USD Million)
Figure 64. UAE Medical Radioisotopes Consumption Value (2018-2029) & (USD Million)
Figure 65. Medical Radioisotopes Market Drivers
Figure 66. Medical Radioisotopes Market Restraints
Figure 67. Medical Radioisotopes Market Trends
Figure 68. Porters Five Forces Analysis
Figure 69. Manufacturing Cost Structure Analysis of Medical Radioisotopes in 2022
Figure 70. Manufacturing Process Analysis of Medical Radioisotopes
Figure 71. Medical Radioisotopes Industrial Chain
Figure 72. Methodology
Figure 73. Research Process and Data Source
